Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2018Hepatology

Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with end-stage liver disease and cirrhotic cardiomyopathy undergoing liver transplantation

Design

Review

Authors

MIManhal IzzyJOJae K. OhKWKymberly D. Watt

Discussion

Loading...

Member takes

Overview

Sparse post-transplant data on cirrhotic cardiomyopathy; leaves open need for prospective studies before changing practice.

Structured PICO

P
Population
Patients with end-stage liver disease and cirrhotic cardiomyopathy undergoing liver transplantation
I
Intervention
Liver transplantation
O
Outcome
Course, prognosis, and reversibility of cirrhotic cardiomyopathy after liver transplantation

Cirrhotic cardiomyopathy may not be fully reversible after liver transplantation and could increase post-transplant complications, highlighting the need for updated diagnostic criteria incorporating modern echocardiographic techniques.

Cite This Study

Izzy et al. (2018) studied this question.

synapsesocial.com/papers/6a8a73e6238a34ecf4722bb7https://doi.org/10.1002/hep.30040
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact and persistence of cirrhotic cardiomyopathy after liver transplantation2016 · 57 citations
  2. 2Alterations in Corrected QT Interval Following Liver Transplant in Patients With End‐Stage Liver Disease2010 · 25 citations
  3. 3Cirrhotic Cardiomyopathy2010 · 366 citations
  4. 4Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease2002 · 370 citations
  5. 5Cardiovascular complications of cirrhosis2008 · 490 citations